E-LIB Suche - Ergebnisse für: Ladigan, Swetlana

1

Secondary resistance to anti-EGFR therapy by transcriptiona..:

Vangala, Deepak ; Ladigan, Swetlana ; Liffers, Sven T....
Genome Medicine. 13 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

2

Evolution of RAS Mutational Status in Liquid Biopsies Durin..:

Klein-Scory, Susanne ; Wahner, Ingo ; Maslova, Marina...
Frontiers in Oncology. 10 (2020) - p. , 2020

Link: https://doi.org/10.3389/..

3

Characterization of a dual BET/HDAC inhibitor for treatment..:

Zhang, Xin ; Zegar, Tim ; Weiser, Tim...
International Journal of Cancer. 147 (2020) 10 - p. 2847-2861 , 2020

Link: https://doi.org/10.1002/..

4

Monocytes-neutrophils-ratio as predictive marker for failur..:

Mika, Thomas ; Ladigan, Swetlana ; Schork, Karin...
Blood Cells, Molecules, and Diseases. 77 (2019) - p. 103-108 , 2019

Link: https://doi.org/10.1016/..

5

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant..:

Mika, Thomas ; Strate, Katharina ; Ladigan, Swetlana...
Frontiers in Medicine. 6 (2019) - p. , 2019

Link: https://doi.org/10.3389/..

6

Acute myeloid leukemia with central diabetes insipidus:

Ladigan, Swetlana ; Mika, Thomas ; Figge, Anja...
Blood Cells, Molecules, and Diseases. 76 (2019) - p. 45-52 , 2019

Link: https://doi.org/10.1016/..

7

Verbundprojekt "Familiärer Darmkrebs": Status der aktuellen..:

Ladigan, Swetlana ; Vangala, Deepak ; Schmiegel, Wolff..
Forum. 32 (2017) 1 - p. 42-48 , 2017

Link: https://doi.org/10.1007/..

8

Secondary resistance to anti-EGFR therapy by transcriptiona..:

Vangala, Deepak ; Ladigan, Swetlana ; Liffers, Sven T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283888/. , 2021

Link: http://www.ncbi.nlm.nih...

9

Secondary resistance to anti-EGFR therapy by transcriptiona..:

Vangala, Deepak ; Ladigan, Swetlana ; Liffers, Sven T...
https://repository.publisso.de/resource/frl:6465944. , 2021

Link: https://repository.publi..

10

Allogeneic hematopoietic stem cell transplantation for prim..:

Mika, Thomas ; Ladigan, Swetlana ; Baraniskin, Alexander...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109742/. , 2020

Link: http://www.ncbi.nlm.nih...

11

Characterization of a dual BET / HDAC inhibitor for treatme..:

Zhang, Xin ; Zegar, Tim ; Weiser, Tim...
https://resolver.sub.uni-goettingen.de/purl?gro-2/133741. , 2020

Link: https://resolver.sub.uni..

12

Evolution of RAS Mutational Status in Liquid Biopsies Durin..:

Klein-Scory, Susanne ; Wahner, Ingo ; Maslova, Marina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378792/. , 2020

Link: http://www.ncbi.nlm.nih...

13

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant..:

Mika, Thomas ; Strate, Katharina ; Ladigan, Swetlana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930172/. , 2019

Link: http://www.ncbi.nlm.nih...

14

Liquid biopsy based HER2 amplification status in gastric ca..:

Klein-Scory, Susanne ; Ladigan-Badura, Swetlana ; Mika, Thomas...
Heliyon. 9 (2023) 11 - p. e21339 , 2023

Link: https://doi.org/10.1016/..

15

The value of bone marrow biopsy for staging of patients wit..:

Margold, Michelle ; Seidel, Sabine ; Kowalski, Thomas...
Neuro-Oncology. 23 (2021) 12 - p. 2076-2084 , 2021

Link: https://doi.org/10.1093/..